SEEK (Drug Discovery) Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 4

  • Investments
  • 1

SEEK (Drug Discovery) General Information

Description

Developer of pharmaceutical drugs intended to bring safe, effective and low-cost treatments to patients. The company specializes in research, development and sell over-the-counter and prescription medicines through modifying existing medicines to improve their efficacy, using existing medicines in new indications and creating new chemical entities as well as operates a number of clinics, enabling clients to improve human health in major disease areas and get cured.

Contact Information

Formerly Known As
PepTcell
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • London BioScience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
+44 07710
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • London BioScience Innovation Centre
  • 2 Royal College Street
  • London NW1 0NH
  • England, United Kingdom
+44 07710

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SEEK (Drug Discovery) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SEEK (Drug Discovery)‘s full profile, request access.

Request a free trial

SEEK (Drug Discovery) Patents

SEEK (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017248680-A1 Chagas antigens and antibodies and compositions, methods and uses thereof Inactive 14-Apr-2016
CA-3020856-A1 Chagas antigens and antibodies and compositions, methods and uses thereof Pending 14-Apr-2016
EP-3442569-A1 Chagas antigens and antibodies and compositions, methods and uses thereof Pending 14-Apr-2016
US-10973897-B2 Chagas antigens and antibodies and compositions, methods and uses thereof Active 14-Apr-2016
US-20170296637-A1 Chagas antigens and antibodies and compositions, methods and uses thereof Active 14-Apr-2016 A61K39/005
To view SEEK (Drug Discovery)’s complete patent history, request access »

SEEK (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SEEK (Drug Discovery) Acquisitions (1)

SEEK (Drug Discovery)’s most recent deal was a Merger/Acquisition with ValiSeek. The deal was made on 08-Apr-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ValiSeek 08-Apr-2014 Merger/Acquisition Drug Discovery
To view SEEK (Drug Discovery)’s complete acquisitions history, request access »

SEEK (Drug Discovery) Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Conservbio London, United Kingdom 2020
TRx Biosciences London, United Kingdom 2019
Tangent Reprofiling London, United Kingdom 2008

SEEK (Drug Discovery) FAQs

  • When was SEEK (Drug Discovery) founded?

    SEEK (Drug Discovery) was founded in 2004.

  • Where is SEEK (Drug Discovery) headquartered?

    SEEK (Drug Discovery) is headquartered in London, United Kingdom.

  • What is the size of SEEK (Drug Discovery)?

    SEEK (Drug Discovery) has 8 total employees.

  • What industry is SEEK (Drug Discovery) in?

    SEEK (Drug Discovery)’s primary industry is Drug Discovery.

  • Is SEEK (Drug Discovery) a private or public company?

    SEEK (Drug Discovery) is a Private company.

  • What is SEEK (Drug Discovery)’s current revenue?

    The current revenue for SEEK (Drug Discovery) is .

  • How much funding has SEEK (Drug Discovery) raised over time?

    SEEK (Drug Discovery) has raised $4.24M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process